Ebg Medaustron Gmbh

This study tests a new approach for people with borderline resectable pancreatic cancer—tumors that are hard to remove surgically. Participants first receive two chemotherapy drugs, then proton radiation combined with another chemo drug, followed by surgery if possible. The goal …

This study tests a high-dose, short-course radiation treatment for people with locally advanced pancreatic cancer that cannot be removed by surgery. The goal is to see if this approach can control tumor growth in the treated area for at least two years. About 30 participants will…

This study is a registry that collects information from about 2,800 tumor patients treated with ion beam therapy at MedAustron. The goal is to track how well the therapy works and what side effects occur. Researchers will measure tumor response, survival, and quality of life over…